Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice

Thyroid cancer comprises different clinical and histological entities. Whereas differentiated (DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary (MTCs) tumors do not uptake radioactive iodine and display aggressive features associated with a poor prognosis. Mor...

Full description

Bibliographic Details
Main Authors: Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma, Fiorenza Gianì, Marco Russo, Livia Manzella, Paolo Vigneri
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Genes
Subjects:
differentiated thyroid cancer
anaplastic thyroid cancer
medullary thyroid cancer
radioactive iodine resistance
molecular alterations
targeted therapy
tyrosine kinase inhibitors
mTOR inhibitors
immunotherapy
clinical trials
Online Access:https://www.mdpi.com/2073-4425/10/9/709

Internet

https://www.mdpi.com/2073-4425/10/9/709

Similar Items